Classifying risk factors for dyskinesia in Parkinson's disease

被引:82
|
作者
Sharma, J. C. [1 ]
Bachmann, C. G. [2 ]
Linazasoro, G. [3 ]
机构
[1] Univ Nottingham, Sherwood Forest Hosp NHS Trust, Nottingham NG7 2RD, England
[2] Univ Gottingen, Dept Clin Neurophysiol, Gottingen, Germany
[3] Fdn Inbiomed, Policlin Gipuzkoa, Ctr Invest Parkinson, San Sebastian, Spain
关键词
Dyskinesia; Levodopa dose per kilogram body weight; Risk factors; Parkinson's disease; LEVODOPA-INDUCED DYSKINESIAS; RECEPTOR GENE POLYMORPHISM; MOTOR FLUCTUATIONS; L-DOPA; BODY-WEIGHT; ONSET AGE; MOLECULAR-MECHANISMS; CLINICAL-FEATURES; ASSOCIATION; THERAPY;
D O I
10.1016/j.parkreldis.2010.06.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Currently there is no classification of risk factors applicable to an individual patient with Parkinson's disease for the development of dyskinesia. Methods: We conducted literature search to identify and classifying risk factors into groups (a) intrinsic vs extrinsic and (b) modifiable vs non-modifiable. Results: Younger age, young age of onset and severity of PD are major intrinsic non-modifiable risk factors for dyskinesia, female gender is another factor but not independent of other factors. Genetic expression and plasticity may determine pre-disposition to age of onset of PD and dyskinesia, these are currently non-modifiable factors arising due to an interaction of intrinsic and extrinsic factors. Lower initial body weight and weight loss during the course of the disease increase the risk of dyskinesia. Levodopa dose per kilogram body weight is a more significant risk factor than absolute levodopa dose. Early use of longer acting non-levodopa (i.e. dopamine agonists) medications delays the onset of dyskinesia. Interaction between body weight, levodopa dose and mode and duration of drug delivery is a significant modifiable factor. Conclusion: Dyskinesia in PD arises as a consequence of the interaction of intrinsic versus extrinsic and modifiable versus non-modifiable factors. Identification and manipulation of modifiable factors for an individual patient may reduce the risk and burden of dyskinesia. Adjustment of levodopa dose according to body weight during the course of the disease seems to be a significant modifiable risk factor for dyskinesia. (C) 2010 Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:490 / 497
页数:8
相关论文
共 50 条
  • [1] Dyskinesia in Parkinson's disease. Pathophysiology and clinical risk factors
    H. Baas
    Journal of Neurology, 2000, 247 (Suppl 4) : IV12 - IV16
  • [2] Dyskinesia in Parkinson's disease. Pathophysiology and clinical risk factors
    Baas, H
    JOURNAL OF NEUROLOGY, 2000, 247 : 12 - 16
  • [3] Risk factors for levodopa-induced dyskinesia in Parkinson's disease patients
    Djuric, Gordana
    Markovic, Vladana
    Pekmezovic, Tatjana
    Tomic, Aleksandra
    Kresojevic, Nikola
    Kostic, Vladimir
    Svetel, Marina
    VOJNOSANITETSKI PREGLED, 2017, 74 (10) : 921 - 926
  • [4] PREDICTING THE RISK OF DYSKINESIA DEVELOPMENT IN PARKINSON'S DISEASE
    Adiguzel, Ahmet
    Ozturk, Unal
    Altinayar, Sibel
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2020, 23 (02): : 224 - 229
  • [5] Risk factors for levodopa-induced dyskinesia in Serbian Parkinson's disease patients
    Markovic, V.
    Djuric, G.
    Pekmezovic, T.
    Kostic, V.
    Svetel, M.
    MOVEMENT DISORDERS, 2013, 28 : S317 - S317
  • [6] Factors associated with dyskinesia in Parkinson's disease in Mainland China
    Zhou, X.
    Fang, L. F.
    Zhou, X. T.
    Zhou, X. X.
    Zhao, Y. W.
    Qin, L. X.
    Tian, Y.
    Wang, Z. Q.
    Sun, Q. Y.
    Xu, Q.
    Li, J. C.
    Guo, J. F.
    Yan, X. X.
    Tang, B. S.
    MOVEMENT DISORDERS, 2019, 34
  • [7] Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China
    Zhou, Xun
    Guo, Jifeng
    Sun, Qiying
    Xu, Qian
    Pan, Hongxu
    Yu, Renhe
    Tan, Jieqiong
    Yan, Xinxiang
    Tang, Beisha
    Fang, Liangjuan
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [8] Parkinson's disease risk factors
    Allam, MF
    del Castillo, AS
    Navajas, RFC
    REVISTA DE NEUROLOGIA, 2003, 36 (08) : 749 - 755
  • [9] Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort
    Eusebi, Paolo
    Romoli, Michele
    Paoletti, Federico Paolini
    Tambasco, Nicola
    Calabresi, Paolo
    Parnetti, Lucilla
    NPJ PARKINSONS DISEASE, 2018, 4
  • [10] Risk factors and predictors of levodopa-induced dyskinesia among multiethnic Malaysians with Parkinson's disease
    Hashim, H. Z.
    Norlinah, M. I.
    Nafisah, W. Y.
    Tan, H. J.
    Raymond, A. A.
    Tamil, A. M.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2014, 124 (03) : 187 - 191